Do Nonsteroidal Anti-Inflammatory Drugs Increase Bleeding Risk After Craniotomy for Brain Surgery? A Systematic...

Area of Science:

• Neurosurgery
• Pharmacology
• Clinical Trials

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used for pain management in patients undergoing craniotomy.
• Concerns exist regarding NSAID safety, specifically the potential for increased postoperative bleeding due to cyclooxygenase inhibition.

Purpose of the Study:

• To evaluate the risk of hemorrhagic complications in patients receiving NSAIDs versus non-NSAID analgesics or placebo after craniotomy for brain surgery.

Main Methods:

• A systematic literature search was performed across major databases (PubMed, Scopus, Web of Science, Cochrane).
• Studies comparing NSAIDs with non-NSAIDs for postoperative analgesia post-craniotomy were included.
• Primary endpoints were all bleeding complications and those requiring surgical intervention; subanalyses included randomized controlled trials (RCTs) and tumor resections.

Main Results:

• Seven studies (five RCTs) with 2251 patients were analyzed.
• No statistically significant difference in overall bleeding complications (RR: 1.05; 95% CI: 0.58, 1.93) was found between NSAID and non-NSAID groups.
• Similarly, no significant increase in bleeding complications requiring surgical intervention was observed (RR: 1.27; 95% CI: 0.51, 3.16).

Conclusions:

• NSAIDs appear to be a safe analgesic option for patients undergoing craniotomy.
• The use of NSAIDs does not significantly elevate the risk of postoperative bleeding complications compared to non-NSAID alternatives.